City
Epaper

UNICEF issues emergency tender to secure mpox vaccines for crisis-hit countries

By ANI | Updated: September 1, 2024 01:45 IST

New York [US], September 1 (ANI/WAM): UNICEF has announced the issuance of an emergency tender for the procurement of ...

Open in App

New York [US], September 1 (ANI/WAM): UNICEF has announced the issuance of an emergency tender for the procurement of monkeypox (mpox) vaccines. Vaccines are considered crucial in containing the mpox outbreak, which has been declared a public health emergency by both the Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organisation (WHO).

The UNICEF tender aims to secure mpox vaccines for the most affected countries, in collaboration with Africa CDC, Gavi, the Vaccine Alliance, WHO, the Pan American Health Organisation, and other partners. This joint effort includes facilitating vaccine donations from existing stockpiles in high-income countries to help curb the ongoing transmission of mpox.

Under the emergency tender, UNICEF will establish conditional supply agreements with vaccine manufacturers, enabling the organisation to purchase and distribute vaccines swiftly once countries and partners have secured financing, confirmed demand and readiness, and met regulatory requirements for vaccine acceptance. WHO is currently reviewing information submitted by manufacturers on August 23, with the Emergency Use Listing review expected to be completed by mid-September.

This year, the Democratic Republic of the Congo, the epicentre of the crisis, has reported more than 18,000 suspected cases of mpox, including 629 deaths, with four out of five fatalities occurring in children.

"Addressing the current mpox vaccine shortage and delivering vaccines to communities in need is of paramount importance. There is also an urgent need for a universal and transparent allocation mechanism to ensure equitable access to mpox vaccines," said Leila Pakkala, Director of UNICEF's Supply Division.

The emergency tender is designed not only to secure immediate access to mpox vaccines but also to expand production. Depending on demand, manufacturers' production capacity, and funding, agreements for up to 12 million doses through 2025 may be established.

Vaccines are just one of several tools used to interrupt transmission and protect communities against mpox. Africa CDC, Gavi, UNICEF, WHO, and partners are also prioritising infection prevention and control, risk communication, and community engagement. UNICEF is deploying personal protection equipment, diagnostic tests, medical treatment kits, hygiene supplies, and tents to countries on the frontline of the crisis, supporting a range of medical countermeasures, including treatment, case isolation, and surveillance. (ANI/WAM)

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

BusinessGold Price on April 8, 2026: Rates of Yellow Meta and Silver Surges; Check Prices In Mumbai, Delhi

MumbaiJalna Man Arrested Over Viral Objectionable Video on Ajit Pawar Plane Crash, Remarks Against CM Devendra Fadnavis

BusinessAeroDef India 2026: Where Atmanirbhar Bharat Takes Flight

BusinessColebrook Bosson Saunders Highlights New Opportunities for Leadership to Drive Performance in Hybrid Environments

MumbaiMumbai Local Train News: Virar Station Ready for 15-Coach Trains; Capacity to Rise by 25% After Successful Trial Run

International Realted Stories

InternationalUN chief welcomes US-Iran ceasefire, calls on parties involved to comply with international law

InternationalBig day for world peace, Iran can start reconstruction, they've had enough, says Trump

International"Iran declared victory by waging asymmetric war in response": former US Treasury counterterrorism analyst

InternationalAmb Vinay Kwatra highlights expanding India-US ties during Vikram Misri's visit to Washington

InternationalDiscussed strong future of India-US ties: Gor after meeting Trump